Molecular and clinicopathological differences by age at the diagnosis of colorectal cancer

Chu Cheng Chang, Pei Ching Lin, Chun Chi Lin, Yuan Tzu Lan, Hung Hsin Lin, Chien Hsing Lin, Shung Haur Yang, Wen Yi Liang, Wei Shone Chen, Jeng Kai Jiang, Jen Kou Lin, Shih Ching Chang*


研究成果: Article同行評審

13 引文 斯高帕斯(Scopus)


We compared the clinicopathological and molecular profiles between different age groups of sporadic colorectal cancer (CRC) patients (age <50, 56–60, 60–70, 70–80, and >80); 1475 CRC patients were enrolled after excluding 30 individuals with Lynch syndrome. The mutation spectra for APC, TP53, KRAS, PIK3CA, FBXW7, BRAF, NRAS, HRAS, TGFbR, Akt1, and PTEN were analyzed using polymerase chain reaction (PCR), followed by MassArray and microsatellite (MSI-high) analysis by performing genotyping. Male patients (74.1%) were significantly predominant to females (25.9%) in the older age group (70–80, >80). There was an insignificantly linear trend between TNM staging and age-onset of CRC diagnosis. Patients aged < 50 had 58.7% diseases in the advanced stages (Stage III: 36.5% and IV: 22.2% respectively), while this decreased to 40.2% (Stage III: 26.2% and IV; 14.0% respectively) in patients >80. The distributions of mutation frequency were similar in majority of the genes studied among different age groups. Additionally, patients aged <50 had significantly higher frequency of MSI-high, PTEN, and HRAS mutations than those of other groups. Age-onset at diagnosis significantly affected overall survival (HR = 1.46; 95% CI: 1.35–1.58), but not cancer-specific survival (HR = 1.08; 95% CI: 0.99–1.18) in multivariate analysis. In conclusion, molecular and clinicopathological differences were not as significant among different age groups of CRC patients as previously suspected.

期刊International Journal Of Molecular Sciences
出版狀態Published - 5 7月 2017


深入研究「Molecular and clinicopathological differences by age at the diagnosis of colorectal cancer」主題。共同形成了獨特的指紋。